Skip to content

Clinical efficacy of electroacupuncture in the treatment of perimenopausal dry eye

Clinical efficacy of electroacupuncture in the treatment of perimenopausal dry eye

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001088
Enrollment
Unknown
Registered
2025-05-31
Start date
2025-06-11
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Electroacupuncture group:Electroacupuncture
Sham Electroacupuncture group:Sham Electroacupuncture

Sponsors

Shanghai Research Institute of Acupuncture and Meridian
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria of dry eye; (2) perimenopausal women; (3) understand and agree to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) complicated with other eye diseases (such as severe blepharitis blepharospasm conjunctivochalasis strabismus amblyopia glaucoma cataract ocular fundus disease ocular trauma etc.); (2) patients with active eye disease or ophthalmologic surgery within 3 months; (3) receiving acupuncture treatment or other dry eye treatment measures that may affect the efficacy evaluation within 1 month; (4) patients with previous electroacupuncture treatment; (5) patients during pregnancy or lactation; (6) patients with severe systemic diseases such as cardiovascular cerebrovascular liver kidney hematopoietic system and mental diseases; (7) patients with autoimmune diseases such as Sjogren's syndrome rheumatoid arthritis lupus erythematosus ankylosing spondylitis; (8) acupoint skin damage ulcer infection scar; (9) allergic to metal and double-sided glue; (10) patients who used sex hormones within 3 months; (11) patients who received treatment for perimenopausal syndrome within 1 month.

Design outcomes

Primary

MeasureTime frame
Schirmer I Test;Ocular Surface Disease Index;

Secondary

MeasureTime frame
Tear Meniscus Height;Numerical Rating Scale;Patient Health Questionnaire-9;Non-invasive tear film break-up time;Tear Fluid mRNA Expression;Chinese Dry Eye-Related Quality of Life Scale;Cornea Fluorescein Staining;Generalized Anxiety Disorder-7;Serum Sex Hormone Levels;Cornea Sensation;Corneal topography;Modified Kupperman Index;

Countries

China

Contacts

Public ContactXiao-Peng Ma

Shanghai Research Institute of Acupuncture and Meridian

pengpengma@163.com13917140446

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026